Key result
TCF7L2 TT genotype links to lower postprandial total triglycerides and VLDL-TG versus CC carriers.
Why the study?
The TCF7L2 rs7903146 T-allele is strongly associated with type 2 diabetes, but its effect on postprandial metabolite levels is unclear.
Does the TCF7L2 rs7903146 TT genotype alter postprandial metabolite and lipid levels compared to the CC genotype in men?
Case-Control (n=62)
No
Does the TCF7L2 rs7903146 TT genotype alter postprandial metabolite and lipid levels compared to the CC genotype in men?
p-value: p=0.03
Homozygous carriers of the TCF7L2 rs7903146 T-allele exhibit an altered postprandial triglyceride response, suggesting a genotype-mediated effect on hepatic lipid regulation.
Hypothesis-generating for TCF7L2 effects on postprandial lipids in men; leaves open clinical relevance for cardiometabolic risk.
The TCF7L2 rs7903146 T-allele shows the strongest association with type 2 diabetes (T2D) among common gene variants. The aim of this study was to assess circulating levels of metabolites following a meal test in individuals carrying the high risk rs790346 TT genotype (cases) and low-risk CC genotype (controls). Sixty-two men were recruited based on TCF7L2 genotype, 31 were TT carriers and 31 were age- and BMI-matched CC carriers. All participants consumed a test meal after 12 hours of fasting. Metabolites were measured using proton nuclear magnetic resonance (NMR) spectroscopy. Metabolomic profiling of TCF7L2 carriers were performed for 141 lipid estimates. TT carriers had lower fasting levels of L-VLDL-L (total lipids in large very low density lipoproteins, p = 0.045), L-VLDL-CE (cholesterol esters in large VLDL, p = 0.03), and L-VLDL-C (total cholesterol in large VLDL, p = 0.045) compared to CC carriers. Additionally, TT carriers had lower postprandial levels of total triglycerides (TG) (q = 0.03), VLDL-TG (q = 0.05, including medium, small and extra small, q = 0.048, q = 0.0009, q = 0.04, respectively), HDL-TG (triglycerides in high density lipoproteins q = 0.037) and S-HDL-TG (q = 0.00003). In conclusion, TT carriers show altered postprandial triglyceride response, mainly influencing VLDL and HDL subclasses suggesting a genotype-mediated effect on hepatic lipid regulation.
No takes yet. Share an insight, caveat, or question.
Engelbrechtsen et al. (2017) conducted a case-control in Healthy (glucose tolerant) (n=62). TCF7L2 rs7903146 TT genotype vs. TCF7L2 rs7903146 CC genotype was evaluated on Postprandial levels of total triglycerides (TG) during a mixed meal test (p=0.03). Homozygous carriers of the TCF7L2 rs7903146 T-allele showed a significantly altered postprandial lipid response, with lower levels of total triglycerides (q=0.03) and VLDL-TG (q=0.05) compared to CC carriers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: